THERESA GARRETT-BELL: Open Payments
NPI 1255036588 · BEXLEY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 51 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $406 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $297 |
| Axsome Therapeutics, Inc. | 7 | $290 |
| Teva Pharmaceuticals USA, Inc. | 4 | $135 |
| Indivior Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Alkermes, Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $17 |
Products named: VRAYLAR, Auvelity, UZEDY, SUBLOCADE, CAPLYTA, REXULTI, ARISTADA, BRIXADI.
Industry payments across OH — which companies pay providers there.
